These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18456392)

  • 1. Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Chun FK
    Eur Urol; 2008 Aug; 54(2):400-1. PubMed ID: 18456392
    [No Abstract]   [Full Text] [Related]  

  • 2. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
    Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
    J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
    Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R
    J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
    Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
    J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
    Yoshida S; Nakagomi K; Goto S; Futatsubashi M; Torizuka T
    Urol Int; 2005; 74(3):214-20. PubMed ID: 15812206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    Oyama N
    Eur Urol; 2007 Aug; 52(2):429. PubMed ID: 17397993
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of penile metastases of prostatic origin with 11C-Choline PET/CT.
    Garcia JR; Aguilo JJ; Marco V; Valls E; Soler M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):295-6. PubMed ID: 22682926
    [No Abstract]   [Full Text] [Related]  

  • 16. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.
    Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A
    J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
    Rinnab L; Mottaghy FM; Simon J; Volkmer BG; de Petriconi R; Hautmann RE; Wittbrodt M; Egghart G; Moeller P; Blumstein N; Reske S; Kuefer R
    Urol Int; 2008; 81(2):191-7. PubMed ID: 18758218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with carbon-11 choline positron emission tomography in prostate carcinoma.
    Kotzerke J; Prang J; Neumaier B; Volkmer B; Guhlmann A; Kleinschmidt K; Hautmann R; Reske SN
    Eur J Nucl Med; 2000 Sep; 27(9):1415-9. PubMed ID: 11007527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?
    Gakis G; Stenzl A
    J Urol; 2015 Jan; 193(1):12-3. PubMed ID: 25444969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.